Multiple, objectively measured sleep dimensions including hypoxic burden and chronic kidney disease: findings from the Multi-Ethnic Study of Atherosclerosis
Open Access
- 30 June 2021
- Vol. 76 (7), 714-722
- https://doi.org/10.1136/thoraxjnl-2020-216422
Abstract
Background Poor sleep may contribute to chronic kidney disease (CKD) through several pathways, including hypoxia-induced systemic and intraglomerular pressure, inflammation, oxidative stress and endothelial dysfunction. However, few studies have investigated the association between multiple objectively measured sleep dimensions and CKD. Methods We investigated the cross-sectional association between sleep dimensions and CKD among 1895 Multi-Ethnic Study of Atherosclerosis Sleep Ancillary Study participants who completed in-home polysomnography, wrist actigraphy and a sleep questionnaire. Using Poisson regression models with robust variance, we estimated separate prevalence ratios (PR) and 95% CIs for moderate-to-severe CKD (glomerular filtration rate 30 mg/g) among participants according to multiple sleep dimensions, including very short (<= 5 hours) sleep, Apnoea-Hypopnoea Index and sleep apnoea-specific hypoxic burden (SASHB) (total area under the respiratory event-related desaturation curve divided by total sleep duration, %min/hour)). Regression models were adjusted for sociodemographic characteristics, health behaviours and clinical characteristics. Results Of the 1895 participants, mean age was 68.2 +/- 9.1 years, 54% were women, 37% were white, 28% black, 24% Hispanic/Latino and 11% Asian. Several sleep metrics were associated with higher adjusted PR of moderate-to-severe CKD: very short versus recommended sleep duration (PR=1.40, 95% CI 1.06 to 1.83); SASHB (Box-Cox transformed SASHB: PR=1.06, 95% CI 1.02 to 1.12); and for participants in the highest quintile of SASHB plus sleep apnoea: PR=1.28, 95% CI 1.01 to 1.63. Conclusions Sleep apnoea associated hypoxia and very short sleep, likely representing independent biological mechanisms, were associated with a higher moderate-to-severe CKD prevalence, which highlights the potential role for novel interventions.Funding Information
- Wellcome Trust (212904/Z/18/Z)
This publication has 35 references indexed in Scilit:
- Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infectionsPublished by Cold Spring Harbor Laboratory ,2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Smoking and sickness absence: a systematic review and meta-analysisScandinavian Journal of Work, Environment & Health, 2019
- Cigarette Smoking: An Assessment of Tobacco’s Global Environmental Footprint Across Its Entire Supply ChainEnvironmental Science & Technology, 2018
- Nicotine without smoke—putting electronic cigarettes in contextBMJ, 2016
- Smoking and Cardiovascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2014
- How cigarette smoke skews immune responses to promote infection, lung disease and cancerNature Reviews Immunology, 2009
- Social inequalities in male mortality, and in male mortality from smoking: indirect estimation from national death rates in England and Wales, Poland, and North AmericaThe Lancet, 2006
- Adjusting multiple testing in multilocus analyses using the eigenvalues of a correlation matrixHeredity, 2005
- Cigarette Smoking and InfectionArchives of Internal Medicine, 2004